Clinical Trial Update: UNITE Study: Understanding New Interventions With GBM ThErapy [Phase 3]

View source ↗

Summary

Phase 3 UNITE trial in glioblastoma multiforme was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• UNITE (Interventions for GBM therapy)

Snippet

Sponsor: AbbVie | Conditions: Glioblastoma Multiforme | Phase 3 | Status: TERMINATED | Results posted: 2021-04-14